OTC Device Claims For COPD ‘Therapy’ Put Patients At Risk – UK Regulator
This article was originally published in The Pink Sheet
Executive Summary
ASA finds device marketer BioLife Solutions could not rely on a disclaimer and use of the word “therapy” instead of “treatment” to offset the message its Airnergy device treats a medical condition. ASA advices not to make COPD treatment claims unless a product is properly certified.